{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:27:35Z","timestamp":1766428055282,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.vaccine.2021.08.079","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T00:35:02Z","timestamp":1632184502000},"page":"6206-6209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6992-4653","authenticated-orcid":false,"given":"Piyada","family":"Angsuwatcharakon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanyawee","family":"Puthanakit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pornumpa","family":"Bunjoungmanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-5537","authenticated-orcid":false,"given":"Suvaporn","family":"Anugulruengkitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patchareeyawan","family":"Srimuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8854-2848","authenticated-orcid":false,"given":"Ekkasit","family":"Kowitdamrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pannada","family":"Savangsindh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiratchaya","family":"Sophonphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terapong","family":"Tantawichien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auchara","family":"Tangsathapornpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.079_b0005","unstructured":"Center for Disease Control Prevention. Facts about Measles & Rubella. https:\/\/www.cdc.gov\/globalhealth\/measles\/facts.htm; 2020 [accessed 25 October 2020]."},{"key":"10.1016\/j.vaccine.2021.08.079_b0010","unstructured":"World Health Organization. Regional Office for South-East Asia. Strategic plan for measles and rubella elimination in WHO South-East Asia Region: 2020\u20132024.World Health Organization. Regional Office for South-East Asia. https:\/\/apps.who.int\/iris\/handle\/10665\/330356; 2019 [accessed 25 October 2020]."},{"issue":"9984","key":"10.1016\/j.vaccine.2021.08.079_b0015","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/S0140-6736(14)60539-0","volume":"385","author":"Lambert","year":"2015","journal-title":"Rubella. Lancet."},{"issue":"8","key":"10.1016\/j.vaccine.2021.08.079_b0020","doi-asserted-by":"crossref","first-page":"e42867","DOI":"10.1371\/journal.pone.0042867","article-title":"Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity","volume":"7","author":"Poethko-M\u00fcller","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.08.079_b0025","unstructured":"Bureau of Epidemiology, Department of Disease Control, Ministry of Public Health, Thailand. Surveillance Data: Rubella. http:\/\/www.boe.moph.go.th\/boedb\/surdata\/disease.php?ds=21; 2020 [accessed 25 October 2020]."},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.079_b0030","doi-asserted-by":"crossref","first-page":"e0225606","DOI":"10.1371\/journal.pone.0225606","article-title":"Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey","volume":"14","author":"Wanlapakorn","year":"2019","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.079_b0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity. Defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am J Clin Pathol."},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.079_b0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3329\/jhpn.v27i1.3320","article-title":"Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles\/MMR immunization programme","volume":"27","author":"Tharmaphornpilas","year":"2009","journal-title":"J Health Popul Nutr."},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.079_b0045","doi-asserted-by":"crossref","first-page":"e0225606","DOI":"10.1371\/journal.pone.0225606","article-title":"Antibodies against measles and rubella virus among different age groups in Thailand: A population-based serological survey","volume":"14","author":"Wanlapakorn","year":"2019","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.079_b0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.vaccine.2020.12.079","article-title":"Immunogenicity, duration of protection, effectiveness and safety of rubella containing vaccines: A systematic literature review and meta-analysis","volume":"39","author":"van den Boogaard","year":"2021","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.08.079_b0055","unstructured":"World Health Organization. Regional Office for South-East Asia. (2019). Expanded programme on Immunization (EPI) factsheet 2019: Thailand. World Health Organization. Regional Office for South-East Asia. https:\/\/apps.who.int\/iris\/handle\/10665\/329990. License: CC BY-NC-SA 3.0 IGO."},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.079_b0060","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine."},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.079_b0065","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1473-3099(08)70282-2","article-title":"Measles, mumps, and rubella in Finland: 25 years of a nationwide elimination programme","volume":"8","author":"Peltola","year":"2008","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.vaccine.2021.08.079_b0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijid.2019.12.015","article-title":"Seroprevalence of vaccine-preventable diseases among children and adolescents in Singapore: Results from the national paediatric seroprevalence survey 2018","volume":"92","author":"Ng","year":"2020","journal-title":"Int J Infect Dis."},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.079_b0075","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.079_b0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/1010539508322698","article-title":"Prevalence of rubella susceptibility among pregnant mothers in a community-based antenatal clinic in Malaysia: a cross-sectional study","volume":"20","author":"Ai Theng","year":"2008","journal-title":"Asia Pac J Public Health."},{"key":"10.1016\/j.vaccine.2021.08.079_b0085","unstructured":"World Health Organization&WHO Expert Committee on Biological Standardization. WHO Expert Committee on Biological Standardization: sixty-eighth report.World Health Organization.https:\/\/apps.who.int\/iris\/handle\/10665\/272807; 2018 [accessed 25 October 2020."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:00:18Z","timestamp":1759402818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21011270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":17,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0264410X21011270"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.079","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}